EndNote’s NIH Output Style Helps You with the new NIH Bibliography Format

We have been getting phone calls of late regarding changes to the NIH bibliography format. As of March 2016, “anyone submitting an application, proposal or report to the NIH must include the PMC reference number (PMCID) when citing applicable papers that they author or that arise from their NIH-funded research.” The other requirement is that all authors of a given article be listed in the bibliographic citation. If you have EndNote, you can kill both birds with one stone.

Back in 2014, the NIH created an EndNote output style called NIH (Grant Format). In this style, all of the authors are included and the PMID and PMCID are added automatically. To see if the NIH format is included in your version of EndNote:

  1. In EndNote for Windows, click on the Bibliographic Output Style drop-down arrow located in the EndNote toolbar.
  2. Check the list provided and click NIH, if it appears.

The drop-down list of output styles is an alphabetical list of your most heavily-used styles. If you do not see NIH on that list, proceed as follows:

  1. In EndNote for Windows, click on the Bibliographic Output Style drop-down arrow located in the EndNote toolbar.
  2. Click Select Another Style.
  3. Output styles are arranged alphabetically by name. Scroll down to and click NIH if it appears on the list.
  4. Click Choose.

If you do not see NIH in the Choose a Style box, it may be installed just not visible:

  1. In EndNote for Windows, click Edit, then click Output Styles, and then click Open Style Manager.
  2. In the EndNote Styles box, scroll down to and select the NIH checkbox.
  3. Close the EndNote Styles box.

If you do not see NIH in the EndNote Styles box, it may not be installed and proceed as follows:

  1. Google EndNote downloads.
  2. Click Downloads | EndNote | Clarivate Analytics
  3. Scroll down to and click Add output styles.
  4. In the text box located directly under the Publisher drop-down list, type NIH.
  5. Click NIH (Grant Format).
  6. Click Download this Style.
  7. In the Opening NIH.ens box, make sure that Open with is selected and EndNote X8 (or X7) appears as the default.
    If you do not see EndNote, click the down arrow then click Other, click EndNote, and then click OK.
  8. Click OK.
  9. In EndNote, click File and then click Save As.
  10. In the Style Name text box, delete Copy if it appears.
  11. Click Save.

If your article has been submitted to PMC by the publisher and does not have a PMCID yet use “PMC Journal – In Process”. If either the publisher, the author, or the author’s designee has submitted the manuscript using the NIHMS, provide a valid NIH Manuscript Submission System reference number (NIHMSID) until the PMCID becomes available. Whatever method of deposit you use, be sure to add the PMCID when it becomes available. If your article was accepted for publication before the NIH Public Access Policy went into effect, then no special notation is required.

For more information about when to include the PMCID see, NIH Public Access Policy Include PMCID in Citation.

Advertisements

Staff Publications – January 2017

1.    Afifi M, Deiab N, El-Farrash A, et al. Su-F-T-281: Monte Carlo Investigation of Sources of Dosimetric Discrepancies with 2d Arrays. Medical physics. 2016;43(6):3527. PMID: 28047911.
2.    Al Ashkar E, Eldib A, Eraba K, Imam M, Ma C. Su-F-T-79: Monte Carlo Investigation of Optimizing Parameters for Modulated Electron Arc Therapy. Medical physics. 2016;43(6):3479. PMID: 28048738.
3.    Andersen CL, Sikora MJ, Boisen MM, et al. Active Estrogen Receptor-Alpha Signaling in Ovarian Cancer Models and Clinical Specimens. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017. PMID: 28073843.
4.    Ariazi EA, Taylor JC, Black MA, et al. A New Role for Eralpha: Silencing Via DNA Methylation of Basal, Stem Cell, and Emt Genes. Molecular cancer research : MCR. 2016. PMID: 28108626.
5.    Bodson J, Ding Q, Warner EL, Hawkins AJ, Henry KA, Kepka D. Sub-Regional Assessment of Hpv Vaccination among Female Adolescents in the Intermountain West and Implications for Intervention Opportunities. Maternal and child health journal. 2017. PMID: 28092058.
6.    Burns KE, Hensley H, Robinson MK, Thevenin D. Therapeutic Efficacy of a Family of Phlip-Mmaf Conjugates in Cancer Cells and Mouse Models. Molecular pharmaceutics. 2017. PMID: 28048942.
7.    Buys SS, Sandbach JF, Gammon A, et al. A Study of over 35,000 Women with Breast Cancer Tested with a 25-Gene Panel of Hereditary Cancer Genes. Cancer. 2017. PMID: 28085182.
8.    Carrer A, Parris JL, Trefely S, et al. Impact of High Fat Diet on Tissue Acyl-Coa and Histone Acetylation Levels. The Journal of biological chemistry. 2017. PMID: 28077572.
9.    Chen L, Cvetkovic D, Chen X, Wang B, Gupta R, Ma C. We-Ab-Bra-02: Study of the Therapeutic Effects of Pulsed Focused Ultrasound Combined with Encapsulated Chemotherapeutic Agents for Prostate Cancer in Vivo. Medical physics. 2016;43(6):3791. PMID: 28048451.
10.    Chen L, Cvetkovic D, Chen X, Wang B, Gupta R, Ma C. Su-F-J-225: Histology Study of Mr Guided Pulsed Focused Ultrasound on Treatment of Prostate Cancer in Vivo. Medical physics. 2016;43(6):3460-3461. PMID: 28046739.
11.    Chibani O, Fan J, Tahanout F, Eldib A, Ma C. Su-F-T-375: Optimization of a New Co-60 Machine for Intensity Modulated Radiation Therapy: A Monte Carlo Characterization Study. Medical physics. 2016;43(6):3549. PMID: 28047825.
12.    Chibani O, Tahanout F, Ma C. Tu-Ab-Brc-04: Commissioning of a New Mlc Model for the Gepts Monte Carlo System: A Model Based on the Leaf and Interleaf Effective Density. Medical physics. 2016;43(6):3730. PMID: 28048146.
13.    Cornell RF, D’Souza A, Kassim AA, et al. Maintenance Versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma. Biology of Blood and Marrow Transplantation. 2017;23(2):269-277.
14.    Costa LJ, Maddocks K, Epperla N, et al. Diffuse Large B-Cell Lymphoma with Primary Treatment Failure: Ultra-High Risk Features and Benchmarking for Experimental Therapies. American Journal of Hematology. 2017;92(2):161-170.
15.    Cvetkovic D, Wang B, Gupta R, Ma C. Su-F-T-674: In Vitro Study of 5-Aminolevulinic Acid-Mediated Photo Dynamic Therapy in Human Cancer Cell Lines. Medical physics. 2016;43(6):3619. PMID: 28048178.
16.    Deer TR, Pope JE, Hayek SM, et al. The Polyanalgesic Consensus Conference (Pacc): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating Risks. Neuromodulation : journal of the International Neuromodulation Society. 2017. PMID: 28042914.
17.    Eldib A, Chibani O, Chen L, Li J, Price R, Ma C. Su-F-T-524: Investigation of the Dosimertric Benefits of Interchangeable Source Size of a Novel Rotating Gamma System. Medical physics. 2016;43(6):3583-3584. PMID: 28047166.
18.    Eldib A, Chibani O, Mora G, et al. Su-F-T-649: Dosimetric Evaluation of Non-Coplanar Arc Therapy Using a Novel Rotating Gamma Ray System. Medical physics. 2016;43(6):3613. PMID: 28046237.
19.    Fan J, Lin T, Jin L, et al. Mo-Fg-Campus-Jep3-05: Evaluation of 4d Ct-on-Rails Target Localization Methods for Free Breathing Liver Stereotactic Body Radiotherapy (Sbrt). Medical physics. 2016;43(6):3727. PMID: 28047328.
20.    Finelli A, Ismaila N, Bro B, et al. Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017:Jco2016699645. PMID: 28095147.
21.    Franco-Barraza J, Francescone R, Luong T, et al. Matrix-Regulated Integrin Alphavbeta5 Maintains Alpha5beta1-Dependent Desmoplastic Traits Prognostic of Neoplastic Recurrence. eLife. 2017;6. PMID: 28139197.
22.    George E, Kim H, Krepler C, et al. A Patient-Derived-Xenograft Platform to Study Brca-Deficient Ovarian Cancers. JCI insight. 2017;2(1):e89760. PMID: 28097235. PMC5214535.
23.    Gross S, Kotova EY, Maluchenko NV, Pascal JM, Studitsky VM. Evaluating Parp1 Domains as Gossypol Targets. Moscow University Biological Sciences Bulletin. 2016;71(4):235-239.
24.    Gupta R, Cvetkovic D, Wang B, Chen L, Ma C. We-Ab-Bra-01: Biodistribution of Paclitaxel-Loaded Nanodroplets for Prostate Cancer Management Using Ultrasound-Mediated Drug Delivery under Mrguidance. Medical physics. 2016;43(6):3791. PMID: 28046379.
25.    Gupta R, Eldib A, Li J, Ma C. Su-F-T-610: Comparison of Output Factors for Small Radiation Fields Used in Sbrt Treatment. Medical physics. 2016;43(6):3604. PMID: 28047767.
26.    Hayakawa K, Formica AM, Brill-Dashoff J, et al. Early Generated B1 B Cells with Restricted Bcrs Become Chronic Lymphocytic Leukemia with Continued C-Myc and Low Bmf Expression. Journal of Experimental Medicine. 2016;213(13):3007-3023.
27.    Huang JF, Zhang FZ, Zou QZ, et al. Induction Chemotherapy Followed by Concurrent Chemoradiation and Nimotuzumab for Locoregionally Advanced Nasopharyngeal Carcinoma: Preliminary Results from a Phase Ii Clinical Trial. Oncotarget. 2017;8(2):2457-2465.
28.    Infante JR, Patnaik A, Verschraegen CF, et al. Two Phase 1 Dose-Escalation Studies Exploring Multiple Regimens of Litronesib (Ly2523355), an Eg5 Inhibitor, in Patients with Advanced Cancer. Cancer chemotherapy and pharmacology. 2017. PMID: 28097385.
29.    Jin L, Fan J, Eldib A, Price R, Ma C. Su-F-T-81: Treating Nose Skin Using Energy and Intensity Modulated Electron Beams with Monte Carlo Based Dose Calculation. Medical physics. 2016;43(6):3480. PMID: 28047422.
30.    John EM, Terry MB, Keegan TH, et al. The Legacy Girls Study: Growth and Development in the Context of Breast Cancer Family History. Epidemiology (Cambridge, Mass). 2016;27(3):438-448. PMID: 26829160.
31.    Kang J, Zhang S, Philbrook S, Paul S, Wang B. Su-F-T-416: Dosimetric Comparison of Coplanar and Non-Coplanar Imrt Plans for Peripheral Lung Lesion. Medical physics. 2016;43(6):3558-3559. PMID: 28047745.
32.    Kelly AD, Kroeger H, Yamazaki J, et al. A Cpg Island Methylator Phenotype in Acute Myeloid Leukemia Independent of Idh Mutations and Associated with a Favorable Outcome. Leukemia. 2017. PMID: 28074068.
33.    Kutikov A, Uzzo RG, Smaldone MC, Haifler M, Bratslavsky G, Leibovich BC. Reply to Patrick O. Richard, Micheal as Jewett and Antonio Finelli’s Letter to the Editor Re: Alexander Kutikov, Marc C. Smaldone, Robert G. Uzzo, Miki Haifler, Gennady Bratslavsky, Bradley C. Leibovich. Renal Mass Biopsy: Always, Sometimes, or Never? Eur Urol. In Press. Http://Dx.Doi.Org/10.1016/J.Eururo.2016.04.001. European Urology. 2017;71(2):E47-E48.
34.    L.ee HO, Wang LQ, Kuo YM, et al. Lack of Global Epigenetic Methylation Defects in Cbs Deficient Mice. Journal of Inherited Metabolic Disease. 2017;40(1):113-120.
35.    Lin T, Ma C. Su-F-J-117: Impact of Motion Artifacts on Image Quality and Accuracy of Tumor Motion Reconstruction in 4d Ct-on-Rails and Mv-Cbct Scans: A Phantom Study. Medical physics. 2016;43(6):3433-3434. PMID: 28048240.
36.    Lin T, Wang L, Galloway T, Ma C. Su-F-J-13: Choosing an Imrt Technique in the Treatment of Head and Neck Cancer with Daily Localization Uncertainties. Medical physics. 2016;43(6):3408. PMID: 28047351.
37.    Litwin S, Basickes S, Ross EA. Two-Sample Binary Phase 2 Trials with Low Type I Error and Low Sample Size. Statistics in medicine. 2017. PMID: 28118686.
38.    Liu J, Eldib A, Lin M, Li J, Mora G, Ma C. Su-G-Brc-08: Evaluation of Dose Mass Histogram as a More Representative Dose Description Method Than Dose Volume Histogram in Lung Cancer Patients. Medical physics. 2016;43(6):3628. PMID: 28047740.
39.    Lydiatt WM, Patel SG, O’Sullivan B, et al. Head and Neck Cancers-Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual. CA: a cancer journal for clinicians. 2017. PMID: 28128848.
40.    Ma C, Chibani O, Eldib A, Li J, Chen L. Su-F-T-529: Dosimetric Investigation of a Rotating Gamma Ray System for Imagedguided Modulated Arc Radiotherapy. Medical physics. 2016;43(6):3584-3585. PMID: 28048393.
41.    Ma C, Wang B, Cvetkovic D, Chen L. Su-F-J-216: Mr-Guided Non-Thermal Pulsed Focused Ultrasound for Cancer Therapy. Medical physics. 2016;43(6):3458. PMID: 28048114.
42.    Ma GX, Fang CY, Seals B, et al. A Community-Based Randomized Trial of Hepatitis B Screening among High-Risk Vietnamese Americans. American journal of public health. 2017:e1-e8. PMID: 28103075.
43.    Manne SL, Virtue SM, Ozga M, et al. A Comparison of Two Psychological Interventions for Newly-Diagnosed Gynecological Cancer Patients. Gynecologic Oncology. 2017;144(2):354-362.
44.    Mesa R, Jamieson C, Bhatia R, et al. Myeloproliferative Neoplasms, Version 2.2017. Journal of the National Comprehensive Cancer Network. 2016;14(12):1572-1611.
45.    Minervini A, Campi R, Sessa F, et al. Positive Surgical Margins and Local Recurrence after Simple Enucleation and Standard Partial Nephrectomy for Malignant Renal Tumors: Systematic Review of the Literature and Meta-Analysis of Prevalence. Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2017. PMID: 28124871.
46.    Mirhadi AJ, Zhang Q, Hanks GE, et al. Effect of Long-Term Hormonal Therapy (Vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on Nrg Oncology Rtog 9202. International journal of radiation oncology, biology, physics. 2017;97(3):511-515. PMID: 28126300.
47.    Mookerjee-Basu J, Kappes DJ. Inkt Cells Do a Fat Lot of Good. Nature Immunology. 2017;18(1):10-12.
48.    O’Malley D, Dewan AA, Ohman-Strickland P, Gundersen DA, Miller SM, Hudson SV. Determinants of Patient Activation in a Community Sample of Breast and Prostate Cancer Survivors. Psycho-oncology. 2017. PMID: 28133892.
49.    Plimack ER, Bellmunt J, Gupta S, et al. Safety and Activity of Pembrolizumab in Patients with Locally Advanced or Metastatic Urothelial Cancer (Keynote-012): A Non-Randomised, Open-Label, Phase 1b Study. The Lancet Oncology. 2017. PMID: 28081914.
50.    Price R, Veltchev I, Lin T, Gleason R, Ma C. Su-F-T-345: Quasi-Dead Beams: Clinical Relevance and Implications for Automatic Planning. Medical physics. 2016;43(6):3542. PMID: 28048497.
51.    Ristau BT, Smaldone MC. Radical Prostatectomy in Metastatic Prostate Cancer: Is There Enough Evidence? Vertical Bar Opinion: No. International Braz J Urol. 2016;42(5):880-882.
52.    Roy I, Boyle KA, Vonderhaar EP, et al. Cancer Cell Chemokines Direct Chemotaxis of Activated Stellate Cells in Pancreatic Ductal Adenocarcinoma. Laboratory investigation; a journal of technical methods and pathology. 2017. PMID: 28092365.
53.    Seabloom DE, Galbraith AR, Haynes AM, et al. Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention. Cancer prevention research (Philadelphia, Pa). 2017. PMID: 28052934.
54.    Semenova G, Stepanova D, Deyev SM, Chernoff J. Medium Throughput Biochemical Compound Screening Identifies Novel Agents for Pharmacotherapy of Neurofibromatosis Type I. Biochimie. 2017. PMID: 28065690.
55.    Shapiro GI, Vaishampayan UN, LoRusso P, et al. First-in-Human Trial of an Anti-5t4 Antibody-Monomethylauristatin Conjugate, Pf-06263507, in Patients with Advanced Solid Tumors. Investigational new drugs. 2017. PMID: 28070718.
56.    Sharma P, Retz M, Siefker-Radtke A, et al. Nivolumab in Metastatic Urothelial Carcinoma after Platinum Therapy (Checkmate 275): A Multicentre, Single-Arm, Phase 2 Trial. The Lancet Oncology. 2017. PMID: 28131785.
57.    Skalka AM, Andrake MD, Katz RA. Successes and Challenges with Retroviral Enzymes. Postepy biochemii. 2016;62(3):280-285. PMID: 28132482.
58.    Soni RS, Ebersole B, Jamal N. Treatment of Chronic Cough. Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2017;156(1):103-108. PMID: 28045638.
59.    Stroup AM, Herget KA, Hanson HA, et al. Baby Boomers and Birth Certificates: Early-Life Socioeconomic Status and Cancer Risk in Adulthood. Cancer Epidemiology Biomarkers and Prevention. 2017;26(1):75-84.
60.    Tan Y, Sementino E, Xu J, et al. The Homeoprotein Dlx5 Drives Murine T-Cell Lymphomagenesis by Directly Transactivating Notch and Upregulating Akt Signaling. Oncotarget. 2017. PMID: 28122332.
61.    Tonisen F, Perrin L, Bayarmagnai B, van den Dries K, Cambi A, Gligorijevic B. Ep4 Receptor Promotes Invadopodia and Invasion in Human Breast Cancer. European journal of cell biology. 2017. PMID: 28094049.
62.    Valieva ME, Gerasimova NS, Kudryashova KS, et al. Stabilization of Nucleosomes by Histone Tails and by Fact Revealed by Spfret Microscopy. Cancers. 2017;9(1). PMID: 28067802.
63.    Veltchev I, Price R, Anderson P, Ma C. Su-F-T-07: Dosimetric Impact of the Dwell Position Inaccuracy in Hdr Ring and Tandem Treatments with Varisourceix Afterloader. Medical physics. 2016;43(6):3462-3463. PMID: 28048740.
64.    Veltchev I, Price R, Horwitz E, Ma C. Su-F-T-34: Transition Form Ct-Based to Ultrasound-Based Hdr Treatment Planning for Prostate Cancer. Medical physics. 2016;43(6):3469. PMID: 28047569.
65.    Waingankar N, Bratslavsky G, Jimenez C, Russo P, Kutikov A. Pheochromocytoma in Urologic Practice. European urology focus. 2016;1(3):231-240. PMID: 28078330. PMC5222610.
66.    Wang B, He W, Cvetkovic D, Chen L, Fan J, Ma C. Su-G-Iep4-11: Monitoring Tumor Growth in Subcutaneous Murine Tumor Model in Vivo: A Comparison between Mri and Small Animal Ct. Medical physics. 2016;43(6):3680. PMID: 28047612.
67.    Wang B, He W, Cvetkovic D, Chen L, Ma C. Su-F-J-215: Non-Thermal Pulsed High Intensity Focused Ultrasound Therapy Combined with 5-Aminolevulinic Acid: An in Vivo Pilot Study. Medical physics. 2016;43(6):3458. PMID: 28048774.
68.    Wang HH, Zaorsky NG, Meng MB, et al. Stereotactic Radiation Therapy for Oligometastases or Oligorecurrence within Mediastinal Lymph Nodes. Oncotarget. 2016;7(14):18135-18145. PMID: 26919113. PMC4951277.
69.    Weitzner BD, Jeliazkov JR, Lyskov S, et al. Modeling and Docking of Antibody Structures with Rosetta. Nature protocols. 2017;12(2):401-416. PMID: 28125104.
70.    Williams SB, Huo J, Chamie K, et al. Discerning the Survival Advantage among Patients with Prostate Cancer Who Undergo Radical Prostatectomy or Radiotherapy: The Limitations of Cancer Registry Data. Cancer. 2017. PMID: 28099688.
71.    Zaorsky NG, Williams GR, Barta SK, et al. Splenic Irradiation for Splenomegaly: A Systematic Review. Cancer treatment reviews. 2016;53:47-52. PMID: 28063304.
72.    Zhang Q, Sun QY, Xiao GP, et al. We-Fg-Bra-12: Research Work of the Radio-Dynamic Treatment Mechanism. Medical physics. 2016;43(6):3826. PMID: 28047568.
73.    Zhang Y, O’Leary MN, Peri S, et al. Ribosomal Proteins Rpl22 and Rpl22l1 Control Morphogenesis by Regulating Pre-Mrna Splicing. Cell reports. 2017;18(2):545-556. PMID: 28076796. PMC5234864.
74.    Zuniga S, Ebersole B, Jamal N. Inpatient Injection Laryngoplasty for Vocal Fold Immobility: When Is It Really Necessary? American journal of otolaryngology. 2017. PMID: 28131551.

EndNote X8 is Here

EndNote X8 is available for download on Machias. For more information about installing EndNote X8 please phone us at (215) 728-2711 or consult our EndNote Libguide. EndNote is not difficult to install yourself, but it is a two-step process. First, you need to install the installer and then you install the program. If you have an earlier version of EndNote installed please create backup copies of your libraries and then uninstall whatever version you have before installing X8.

Here is what’s new in EndNote X8

  1. Share your library with up to 100 other EndNote desktop users on X7.2 or later; providing teams with immediate real time access to the same set of references, attachments, notes and annotations.
  2. Access the Activity Feed to see what your colleagues are doing in the Shared Library and when new members join.
  3. New, modern, easy to identify icons – identical across both Mac and Windows.
  4. Updated workflows for finding reference updates.
  5. Every X8 library includes a built in Recently Added group which can be customized, allowing users to pick up right where they left off in the research workflow.
  6. Configure Sync option in the Groups pane to simplify desktop activation process.
  7. Utilize unlimited file attachment storage in your online library.
  8. Cite While You Write for Microsoft Word 2016.

We at the library are being trained on some of the new features including the improved sharing features. We will be sharing our knowledge with you.

 

Staff Publications – December 2016

1. Abdel-Misih SR, Wei L, Benson AB, 3rd, et al. Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(12):1528-1534. PMID: 27956537.

2. Acquati C, Reese JB, Karam E, Kayser K, Mark K, Wittmann D. A Systematic Review of Dyadic Studies Examining Relationship Quality in Couples Facing Colorectal Cancer Together. Psycho-oncology. 2016. PMID: 27943551.

3. Antonia SJ, Gettinger SN, Goldman J, et al. Oral01.03: Checkmate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced Nsclc: Topic: Medical Oncology. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016;11(11s):S250-s251. PMID: 27969442.

4. Berger ER, Wang CE, Kaufman CS, et al. National Accreditation Program for Breast Centers Accreditation Demonstrates Improved Compliance with Post-Mastectomy Radiation Therapy Quality Measure. Journal of the American College of Surgeons. 2016. PMID: 27993697.

5. Cahn DB, Ristau BT, Uzzo RG, Smaldone MC. Morbidity and Mortality of Radical Nephrectomy for Patients with Disseminated Cancer: An Analysis of the National Surgical Quality Improvement Program Database. Urology. 2016;95:101-102.

6. Camacho-Rivera M, Ragin C, Roach V, Kalwar T, Taioli E. Breast Cancer Clinical Characteristics and Outcomes in Trinidad and Tobago. Journal of immigrant and minority health. 2015;17(3):765-772. PMID: 24146313.

7. Chang EI, Bradley JP. Reply: Long-Term Operative Outcomes of Preoperative Computed Tomography-Guided Virtual Surgical Planning for Osteocutaneous Free Flap Mandible Reconstruction. Plastic and Reconstructive Surgery. 2016;138(4):775E-775E.

8. Chen RW, Li H, Bernstein SH, et al. Rb but Not R-Hcvad Is a Feasible Induction Regimen Prior to Auto-Hct in Frontline Mcl: Results of Swog Study S1106. British journal of haematology. 2016. PMID: 27992063.

9. Chera B, Wang K, Monroe A, et al. Truth or Myth: Definitive Chemoradiotherapy Doesn’t Work for Hpv/P16 Negative Oropharyngeal Squamous Cell Carcinoma? Oral oncology. 2016. PMID: 27993466.

10. Chwistek M. Winter Morning. Annals of internal medicine. 2016;165(12):886. PMID: 27992913.

11. Consedine NS, Tuck NL, Ragin CR, Spencer BA. Beyond the Black Box: A Systematic Review of Breast, Prostate, Colorectal, and Cervical Screening among Native and Immigrant African-Descent Caribbean Populations. Journal of immigrant and minority health. 2015;17(3):905-924. PMID: 24522436.

12. Correa AF, Kutikov A. Editorial Comment. Urology. 2016. PMID: 28034531.

13. Cruz OV, Prudnikova TY, Araiza-Olivera D, et al. Reduced Pak1 Activity Sensitizes Fa/Brca-Proficient Breast Cancer Cells to Parp Inhibition. Oncotarget. 2016;7(47):76590-76603.

14. Daly MB, Pilarski R, Berry M, et al. Nccn Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. Journal of the National Comprehensive Cancer Network : JNCCN. 2017;15(1):9-20. PMID: 28040716.

15. Doss M. Changing the Paradigm of Cancer Screening, Prevention, and Treatment. Dose-response : a publication of International Hormesis Society. 2016;14(4):1559325816680539. PMID: 27928220. PMCID: PMC5134297.

16. Esselen KM, Cronin AM, Bixel K, et al. Use of Ca-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer. Obstetrical and Gynecological Survey. 2016;71(11):660-661.

17. Ettinger DS, Wood DE, Akerley W, et al. Nccn Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(3):255-264. PMID: 26957612.
18. Fatkhullina AR, Peshkova IO, Koltsova EK. The Role of Cytokines in the Development of Atherosclerosis. Biochemistry-Moscow. 2016;81(11):1358-1370. PMID: WOS:000388960400013.
19. Flynn KE, Carter J, Lin L, et al. Assessment of Vulvar Discomfort with Sexual Activity among Women in the United States. American journal of obstetrics and gynecology. 2016. PMID: 27988269.

20. Fuletra JG, Ristau BT, Milestone B, et al. Angiosarcoma of the Adrenal Gland Treated Using a Multimodal Approach. Urology case reports. 2017;10:38-41. PMID: 27920990. PMICD: PMC5137173.

21. Ghiraldi E, Reddy M, Li T, Lawler AC, Friedlander J. Factors Associated with Compliance in Submitting 24-Hour Urine Collections in an Underserved Community. Journal of endourology. 2016. PMID: 27931114.

22. Golan S, Johnson S, Maurice M, et al. Safety and Early Effectiveness of Robotic Partial Nephrectomy for Large Angiomyolipomas. BJU international. 2016. PMID: 27988984.

23. Guha M, Srinivasan S, Guja K, et al. Hnrnpa2 Is a Novel Histone Acetyltransferase That Mediates Mitochondrial Stress-Induced Nuclear Gene Expression. Cell discovery. 2016;2:16045. PMID: 27990297. PMC5148442.

24. Haber AD. The Law of Unintended Consequences. Annals of internal medicine. 2016;165(11):824-825. PMID: 27919093.

25. Hahn NM, Bivalacqua TJ, Ross AE, et al. A Phase Ii Trial of Dovitinib in Bcg-Unresponsive Urothelial Carcinoma with Fgfr3 Mutations or over-Expression: Hoosier Cancer Research Network Trial Hcrn 12-157. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016. PMID: 27932416.

26. Haifler M, Mor Y, Dotan Z, Ramon J, Zilberman DE. Prophylactic Antibiotic Treatment Following Laparoscopic Robot-Assisted Radical Prostatectomy for the Prevention of Catheter-Associated Urinary Tract Infections: Did the Aua Guidelines Make a Difference? Journal of robotic surgery. 2016. PMID: 27987067.

27. Hellmann MD, Rizvi NA, Goldman JW, et al. Nivolumab Plus Ipilimumab as First-Line Treatment for Advanced Non-Small-Cell Lung Cancer (Checkmate 012): Results of an Open-Label, Phase 1, Multicohort Study. The Lancet Oncology. 2016. PMID: 27932067.

28. Henry RA, Mancuso P, Kuo YM, et al. Interaction with the DNA Repair Protein Thymine DNA Glycosylase Regulates Histone Acetylation by P300. Biochemistry. 2016;55(49):6766-6775. PMID: 27951654.

29. Huang JF, Zhang FZ, Zou QZ, et al. Induction Chemotherapy Followed by Concurrent Chemoradiation and Nimotuzumab for Locoregionally Advanced Nasopharyngeal Carcinoma: Preliminary Results from a Phase Ii Clinical Trial. Oncotarget. 2016. PMID: 27974693.

30. Johnson ME, Zaorsky NG, Martin JM, et al. Patient Reported Outcomes among Treatment Modalities for Prostate Cancer. The Canadian journal of urology. 2016;23(6):8535-8545. PMID: 27995848.

31. Johnson SF, Cruz C, Greifenberg AK, et al. Cdk12 Inhibition Reverses De Novo and Acquired Parp Inhibitor Resistance in Brca Wild-Type and Mutated Models of Triple-Negative Breast Cancer. Cell Reports. 2016;17(9):2367-2381.

32. Joseph GA, Lu M, Radu M, et al. Group I Paks Promote Skeletal Myoblast Differentiation in Vivo and in Vitro. Molecular and cellular biology. 2016. PMID: 27920252.

33. Judd J, Dulaimi E, Li T, et al. Low Level of Blood Cd4+ T Cells Is an Independent Predictor of Inferior Progression-Free Survival in Diffuse Large B-Cell Lymphoma. Clinical lymphoma, myeloma & leukemia. 2016. PMID: 28027895.

34. Jung K, Ghatalia P, Litwin S, et al. Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review. Clinical genitourinary cancer. 2016. PMID: 27991416.

35. Kim SP, Campbell SC, Gill I, et al. Collaborative Review of Risk Benefit Trade-Offs between Partial and Radical Nephrectomy in the Management of Anatomically Complex Renal Masses. European urology. 2016. PMID: 27988238.

36. Malhotra S, Karanicolas J. When Does Chemical Elaboration Induce a Ligand to Change Its Binding Mode? Journal of medicinal chemistry. 2016. PMID: 27982595.

37. Manne SL, Myers-Virtue S, Darabos K, et al. Emotional Processing During Psychotherapy among Women Newly Diagnosed with a Gynecological Cancer. Palliative & supportive care. 2016:1-12. PMID: 27964770.

38. Mookerjee-Basu J, Kappes DJ. Inkt Cells Do a Fat Lot of Good. Nature immunology. 2016;18(1):10-12. PMID: 27984570.

39. Moore KN, Martin LP, O’Malley DM, et al. Safety and Activity of Mirvetuximab Soravtansine (Imgn853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016:Jco2016699538. PMID: 28029313.

40. Newman LA, Stark A, Chitale D, et al. Association between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer. JAMA oncology. 2016. PMID: 28006062.

41. Nizovtseva EV, Clauvelin N, Todolli S, et al. Nucleosome-Free DNA Regions Differentially Affect Distant Communication in Chromatin. Nucleic acids research. 2016. PMID: 27940560.

42. Pallera A, Altman JK, Berman E, et al. Nccn Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(12):1505-1512. PMID: 27956535.

43. Punwani D, Zhang Y, Yu J, et al. Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant Bcl11b. The New England journal of medicine. 2016;375(22):2165-2176. PMID: 27959755.

44. Ragin C, Liu JC, Jones G, et al. Prevalence of Hpv Infection in Racial-Ethnic Subgroups of Head and Neck Cancer Patients. Carcinogenesis. 2016. PMID: 28025390.

45. Raje NS, Faber EA, Richardson PG, et al. Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma. Clinical Cancer Research. 2016;22(23):5688-5695.

46. Ramakodi MP, Devarajan K, Blackman E, et al. Integrative Genomic Analysis Identifies Ancestry-Related Expression Quantitative Trait Loci on DNA Polymerase Β and Supports the Association of Genetic Ancestry with Survival Disparities in Head and Neck Squamous Cell Carcinoma. Cancer. 2016.

47. Ramos JD, Casey MF, Crabb SJ, et al. Venous Thromboembolism in Metastatic Urothelial Carcinoma or Variant Histologies: Incidence, Associative Factors, and Effect on Survival. Cancer medicine. 2016. PMID: 28000388.

48. Rimm D, Han G, Taube JM, et al. Oral01.01: A Prospective, Multi-Institutional Assessment of Four Assays for Pd-L1 Expression in Nsclc by Immunohistochemistry: Topic: Pathology. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016;11(11s):S249. PMID: 27969440.

49. Rose TL, Deal AM, Ladoire S, et al. Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer. Bladder cancer (Amsterdam, Netherlands). 2016;2(4):405-413. PMID: 28035321. PMC5181658.

50. Shaw AT, Spigel DR, Tan DS, et al. Mini01.01: Whole Body and Intracranial Efficacy of Ceritinib in Alk-Inhibitor Naive Patients with Alk+ Nsclc and Brain Metastases: Results of Ascend 1 and 3: Topic: Medical Oncology. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016;11(11s):S256. PMID: 27969450.

51. Shi E, Chmielecki J, Tang CM, et al. Fgfr1 and Ntrk3 Actionable Alterations in “Wild-Type” Gastrointestinal Stromal Tumors. Journal of translational medicine. 2016;14(1):339. PMID: 27974047. PMC5157084.

52. Siddiqui F, Smith RV, Yom SS, et al. Acr Appropriateness Criteria(R) Nasal Cavity and Paranasal Sinus Cancers. Head & neck. 2016. PMID: 28032679.

53. Thunnissen E, Borczuk AC, Flieder DB, et al. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016. PMID: 27998793.

54. Volokh OI, Derkacheva NI, Studitsky VM, Sokolova OS. Structural Studies of Chromatin Remodeling Factors. Molecular Biology. 2016;50(6):812-822.

55. Voss MH, Bhatt RS, Plimack ER, et al. The Dart Study: Results from the Dose-Escalation and Expansion Cohorts Evaluating the Combination of Dalantercept Plus Axitinib in Advanced Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016. PMID: 28031424.

56. Wang EH, Yu JB, Abouassally R, et al. Disparities in Treatment of Patients with High-Risk Prostate Cancer: Results from a Population-Based Cohort. Urology. 2016;95:88-94.

57. Weidhaas JB, Harris J, Schaue D, et al. The Kras-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA oncology. 2016. PMID: 28006059.

58. Weldon CB, Madenci AL, Boikos SA, et al. Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report from the National Institutes of Health Pediatric and Wildtype Gist Clinic. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016:Jco2016686733. PMID: 28029307.

59. Zendejas B, Jakub JW, Terando AM, et al. Laparoscopic Skill Assessment of Practicing Surgeons Prior to Enrollment in a Surgical Trial of a New Laparoscopic Procedure. Surgical endoscopy. 2016. PMID: 27928664.

Staff Publications-November 2016

1.    Balasubramanian S, Rajagopalan M, Bojja RS, Skalka AM, Andrake MD, Ramaswamy A. The conformational feasibility for the formation of reaching dimer in ASV and HIV integrase: a molecular dynamics study. Journal of biomolecular structure & dynamics. 2016:1-17 PMID: 27835934.

2.    Bansal P, Osman D, Gan GN, Simon GR, Boumber Y. Recent Advances in Immunotherapy in Metastatic NSCLC. Frontiers in oncology. 2016;6:239 PMID: 27896216.

3.    Barta SK, Li HL, Hochster HS, et al. Randomized Phase 3 Study in Low-Grade Lymphoma Comparing Maintenance Anti-CD20 Antibody With Observation After Induction Therapy: A Trial of the ECOG-ACRIN Cancer Research Group (E1496). Cancer. 2016;122(19):2996-3004.

4.    Beck TN, Smith CH, Flieder DB, et al. Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1. Head & neck. 2016 PMID: 27859938.

5.    Chang HW, Pandey M, Kulaeva OI, Patel SS, Studitsky VM. Overcoming a nucleosomal barrier to replication. Science advances. 2016;2(11):e1601865 PMID: 27847876. PMCID: PMC5106197.

6.    Cornell RF, D’Souza A, Kassim AA, et al. Maintenance Versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 PMID: 27864161.

7.    Costa LJ, Maddocks K, Epperla N, et al. Diffuse Large B-Cell Lymphoma with Primary Treatment Failure: Ultra-high Risk Features and Benchmarking for Experimental Therapies. American journal of hematology. 2016 PMID: 27880984.

8.    Fahl SP, Wang M, Zhang Y, Duc AC, Wiest DL. Regulatory Roles of Rpl22 in Hematopoiesis: An Old Dog with New Tricks. Critical reviews in immunology. 2015;35(5):379-400 PMID: 26853850. PMCID: PMC5111805.

9.    Fang CY, Ma GX, Handorf EA, et al. Addressing multilevel barriers to cervical cancer screening in Korean American women: A randomized trial of a community-based intervention. Cancer. 2016 PMID: 27869293.

10.    Gaponova AV, Deneka AY, Beck TN, et al. Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin. Oncotarget. 2016 PMID: 27863405.

11.    Garrigan C, Han J, Tolomeo P, et al. Evaluation of a research use only luminex based assay for measurement of procalcitonin in serum samples. American journal of translational research. 2016;8(10):4362-4369 PMID: 27830020. PMCID: PMC5095329.
12.    Gopas J, Stern E, Zurgil U, et al. Reed-Sternberg cells in Hodgkin’s lymphoma present features of cellular senescence. Cell death & disease. 2016;7(11):e2457 PMID: 27831553.

13.    Jiang W, Dulaimi E, Devarajan K, et al. Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma. Plos One. 2016;11(10).

14.    Jochems C, Hodge JW, Fantini M, et al. An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele. Oncotarget. 2016 PMID: 27861156.

15.    Johnson SF, Cruz C, Greifenberg AK, et al. CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer. Cell reports. 2016;17(9):2367-2381 PMID: 27880910.

16.    Joshi S, Kutikov A. Editorial Comment. The Journal of urology. 2016 PMID: 27821261.

17.    Joshi SS, Chen DY. Editorial Comment. The Journal of urology. 2016 PMID: 27836456.

18.    Jung K, Zeng X, Bilusic M. Nivolumab-associated acute glomerulonephritis: a case report and literature review. BMC nephrology. 2016;17(1):188 PMID: 27876011. PMCID: PMC5120473.

19.    Li JG, Barrero C, Gupta S, Kruger WD, Merali S, Pratico D. Homocysteine modulates 5-lipoxygenase expression level via DNA methylation. Aging cell. 2016 PMID: 27896923.

20.    Manne SL, Kashy D, Siegel SD, Heckman CJ. Group therapy processes and treatment outcomes in two couple-focused group interventions for breast cancer patients. Psycho-oncology. 2016 PMID: 27885746.

21.    Manne SL, Myers-Virtue S, Kashy DA, et al. Therapy Processes, Progress, and Outcomes for Two Therapies for Gynecological Cancer Patients. Psycho-oncology. 2016 PMID: 27870116.

22.    Manne SL, Virtue SM, Ozga M, et al. A comparison of two psychological interventions for newly-diagnosed gynecological cancer patients. Gynecologic oncology. 2016 PMID: 27887806.

23.    Miller KD, Schnell MJ, Rall GF. Keeping it in check: chronic viral infection and antiviral immunity in the brain. Nature reviews Neuroscience. 2016;17(12):766-776 PMID: 27811921.

24.    Pinheiro PS, Callahan KE, Ragin C, Hage RW, Hylton T, Kobetz EN. Black Heterogeneity in Cancer Mortality: US-Blacks, Haitians, and Jamaicans. Cancer control : journal of the Moffitt Cancer Center. 2016;23(4):347-358 PMID: 27842324.

25.    Rebbeck TR, Friebel TM, Mitra N, et al. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast cancer research : BCR. 2016;18(1):112 PMID: 27836010, PMCID: PMC5106833.

26.    Reese JB, Sorice K, Beach MC, et al. Patient-provider communication about sexual concerns in cancer: a systematic review. Journal of cancer survivorship : research and practice. 2016 PMID: 27858322.

27.    Rice TW, Lerut T, Orringer MB, et al. Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data. Diseases of the Esophagus. 2016;29(7):715-723.

28.    Sato T, Cesaroni M, Chung W, et al. Transcriptional Selectivity of Epigenetic Therapy in Cancer. Cancer research. 2016 PMID: 27879268.

29.    Shah AY, Karam JA, Malouf GG, et al. Management and Outcomes of Patients with Renal Medullary Carcinoma: A Multi-Center Collaborative Study. BJU international. 2016 PMID: 27860149.

30.    Shaikh T, Handorf EA, Murphy CT, Mehra R, Ridge JA, Galloway TJ. The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer. International journal of radiation oncology, biology, physics. 2016;96(5):967-975 PMID: 27869097.

31.    Shields PG, Herbst RS, Arenberg D, et al. Smoking Cessation, Version 1.2016 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2016;14(11):1430-1468.

32.    Siminoff LA, Traino HM, Mosavel M, Barker L, Gudger G, Undale A. Family decision maker perspectives on the return of genetic results in biobanking research. Genetics in medicine : official journal of the American College of Medical Genetics. 2016;18(1):82-88 PMID: 25856669. PMCID: PMC4600004.

33.    Smaldone MC, Egleston B, Hollingsworth JM, et al. Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data. Medical care. 2016 PMID: 27820596.

34.    Smith A, Handorf E, Arjmand E, Lango MN. Predictors of regional Medicare expenditures for otolaryngology physician services. The Laryngoscope. 2016 PMID: 27859299.

35.    Stabler CT, Lecht S, Lazarovici P, Lelkes PI. Mesenchymal stem cells for therapeutic applications in pulmonary medicine. British medical bulletin. 2015;115(1):45-56 PMID: 26063231.

36.    Steen HC, Kotredes KP, Nogusa S, Harris MY, Balachandran S, Gamero AM. Phosphorylation of STAT2 on serine-734 negatively regulates the IFN-alpha-induced antiviral response. Journal of cell science. 2016;129(22):4190-4199 PMID: 27802159.

37.    Sturgeon KM, Dean LT, Heroux M, et al. Commercially available lifestyle modification program: randomized controlled trial addressing heart and bone health in BRCA1/2+ breast cancer survivors after risk-reducing salpingo-oophorectomy. Journal of cancer survivorship : research and practice. 2016 PMID: 27873046.

38.    Thapa RJ, Ingram JP, Ragan KB, et al. DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death. Cell Host and Microbe. 2016;20(5):674-681.

39.    Turner RM, 2nd, Yecies TS, Yabes JG, et al. Biopsy Perineural Invasion in Prostate Cancer Patients Who are Candidates for Active Surveillance by Strict and Expanded Criteria. Urology. 2016 PMID: 27864108.

40.    Valieva ME, Armeev GA, Kudryashova KS, et al. Large-scale ATP-independent nucleosome unfolding by a histone chaperone. Nature structural & molecular biology. 2016 PMID: 27820806.

41.    Van Cleave JH, Egleston BL, Abbott KM, Hirschman KB, Rao A, Naylor MD. Multiple Chronic Conditions and Hospitalizations Among Recipients of Long-Term Services and Supports. Nursing research. 2016;65(6):425-434 PMID: 27801713.

42.    VanderWalde N, Jagsi R, Dotan E, et al. NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(11):1357-1370 PMID: 27799507.

43.    Wen KY, Miller SM, Roussi P, et al. A content analysis of self-reported barriers and facilitators to preventing postpartum smoking relapse among a sample of current and former smokers in an underserved population. Health education research. 2015;30(1):140-151 PMID: 25099776. PMCID: PMC4296888.

44.    Zaorsky NG, Churilla TM, Egleston BL, et al. Causes of death among cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology. 2016 PMID: 27831506.

45.    Zhang BW, Xia J, Tan Z, Levy RM. A Stochastic Solution to the Unbinned WHAM Equations. The journal of physical chemistry letters. 2015;6(19):3834-3840 PMID: 26722879, PMCID: PMC4894662.

46.    Zhao YZ, Zhang M, Wong HL, et al. Prevent diabetic cardiomyopathy in diabetic rats by combined therapy of aFGF-loaded nanoparticles and ultrasound-targeted microbubble destruction technique. Journal of controlled release : official journal of the Controlled Release Society. 2016;223:11-21 PMID: 26712588.

47.    Zhou C, Martinez E, Di Marcantonio D, et al. JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia. Leukemia. 2016 PMID: 27840425.

48.    Zibelman M, Ramamurthy C, Plimack ER. Emerging role of immunotherapy in urothelial carcinoma-Advanced disease. Urologic oncology. 2016;34(12):538-547 PMID: 27888981.